Measuring the Risk of Gluten Exposure: Development of the Gluten Exposure Risk Assessment in Pediatric Patients

Amy E Hale1,2, Monique Germone3,4, Lisa Fahey5,6

  • 1Division of Gastroenterology and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.

Insights

A new screening tool called the Gluten Exposure Risk Assessment (GERA) helps identify children with Celiac Disease (CeD) at risk for gluten exposure. This validated measure aids in assessing adherence to a gluten-free diet (GFD) and guides necessary interventions.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Psychology
  • Dietary Adherence Research

Background:

  • Celiac Disease (CeD) management necessitates a strict gluten-free diet (GFD).
  • Assessing GFD adherence and identifying gluten exposure risks in pediatric CeD patients is challenging.
  • No validated screening tools currently exist for pediatric gluten exposure risk.

Purpose of the Study:

  • To develop and validate a screening measure for assessing gluten exposure risk in pediatric CeD patients.
  • To provide a tool for caregivers to evaluate potential gluten exposure.
  • To identify children who may require further intervention to manage their GFD.

Main Methods:

  • The Gluten Exposure Risk Assessment (GERA) was developed through a modified Delphi process.
  • Psychometric properties, factor structure, and validity were examined in caregivers of pediatric CeD patients.
  • Confirmatory factor analysis (CFA) and test-retest reliability were used to validate the final measure.

Main Results:

  • An initial 134 items were refined to a 10-item measure (1 screening question, 9 validated items) across two domains (Home, Outside).
  • Psychometric and CFA data from 484 caregivers supported the measure's structure.
  • Validation in an independent sample (N=369) confirmed the factor structure and reliability (CFI = 0.96, TLI = 0.95, RMSEA = 0.06).

Conclusions:

  • The Gluten Exposure Risk Assessment (GERA) is a validated caregiver-completed screening tool for assessing gluten exposure risk in pediatric CeD.
  • GERA assists in identifying children at risk for gluten exposure despite a GFD.
  • This tool can guide clinical decisions regarding interventions for improved GFD adherence.
Abstract